Abstract:CRISPR-based gene activation (CRISPRa) is a promising therapeutic approach for gene therapy, upregulating gene expression by targeting promoters or enhancers in a tissue/cell-type specific manner. Here, we describe an experimental framework that combines highly multiplexed perturbations with single-cell RNA sequencing (sc-RNA-seq) to identify cell-type-specific, CRISPRa-responsive regulatory elements and the gene(s) they regulate. Random combinations of many gRNAs are introduced to each of many cells, which are then profiled and partitioned into test and control groups to test for effect(s) of CRISPRa perturbations of both enhancers and promoters on the expression of neighboring genes. Applying this method to a library of 493 gRNAs targeting candidate regulatory elements in both K562 cells and iPSC-derived excitatory neurons, we identify gRNAs capable of specifically upregulating intended target genes and no other neighboring genes within 1 Mb, including gRNAs yielding upregulation of six autism spectrum disorder (ASD) and neurodevelopmental disorder (NDD) risk genes in neurons. A consistent pattern is that the responsiveness of individual enhancers to CRISPRa is restricted by cell type, implying a dependency on either chromatin landscape and/or additional acting factors for successful gene activation. The approach outlined here may facilitate large-scale screens for gRNAs that activate therapeutically relevant genes in a cell type-specific manner.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to identify cis - regulatory elements (cCREs) that can respond to CRISPR activation (CRISPRa) in specific cell types, as well as the genes regulated by these elements. Specifically, the researchers developed an experimental framework, combining highly multiplexed perturbations and single - cell RNA sequencing (sc - RNA - seq), to identify CRISPRa - responsive cis - regulatory elements in specific cell types and the genes they regulate. ### Main problems: 1. **Identifying CRISPRa - responsive cis - regulatory elements in specific cell types**: - The researchers hope to find enhancers and promoters that can respond to CRISPRa in specific cell types. - The responsiveness of these elements may vary in different cell types, so testing in multiple cell types is required. 2. **Validating the function of cis - regulatory elements**: - Through the CRISPRa technology, researchers can test whether candidate cis - regulatory elements can up - regulate the expression of target genes. - Of particular interest are those risk genes associated with autism spectrum disorder (ASD) and neurodevelopmental disorders (NDD). 3. **Exploring the potential of CRISPRa in therapeutic applications**: - By identifying cis - regulatory elements in specific cell types, the researchers hope to develop "cis - regulatory therapy" (CRT) for specific diseases. - For example, for monogenic forms of obesity and autism, CRISPRa technology may help up - regulate the expression of genes related to low - dose. ### Experimental design: - **Cell types**: The researchers selected K562 cells (a chronic myeloid leukemia cell line) and excitatory neurons derived from induced pluripotent stem cells (iPSC) as model systems. - **gRNA library**: A library containing 493 gRNAs was constructed, which target candidate promoters and enhancers. - **CRISPRa system**: Two different activation complexes (VP64 and VPR) were used to test their effects on gene expression. - **Single - cell RNA sequencing**: Through sc - RNA - seq technology, researchers were able to analyze the expression of gRNAs in each cell and their effects on gene expression. ### Results: - **K562 cells**: Multiple gRNAs that can specifically up - regulate target genes were successfully identified, including gRNAs targeting promoters and enhancers. - **iPSC - derived neurons**: Multiple gRNAs that can specifically up - regulate target genes were also identified, especially promoters and enhancers specific to neurons. - **Cell - type specificity**: It was found that the responsiveness of enhancers shows significant differences in different cell types, indicating that the activity of enhancers depends on cell - type - specific chromatin landscapes or transcription factors. Through this research, the authors provide an efficient method for screening and validating cis - regulatory elements in specific cell types, providing important tools and ideas for future gene therapy.

Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements

Higher-order combinatorial chromatin perturbations by engineered CRISPR-Cas12a for functional genomics

A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity

Abstract 2949: A flexible and efficient approach for single-cell CRISPR perturbation screens combined with targeted RNA-seq expression analysis

Sensitive dissection of a genomic regulatory landscape using bulk and targeted single-cell activation

Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing

A genome-scale single cell CRISPRi map of trans gene regulation across human pluripotent stem cell lines

Multiplex profiling of developmental cis- regulatory elements with quantitative single-cell expression reporters

Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations

3092 – CRISPR OPTIMIZATION TO SCREEN FOR GENES THAT REGULATE FATE SPECIFICATION OF PRIMARY HUMAN HEMATOPOIETIC PROGENITORS

Linking Genotypes with Multiple Phenotypes in Single-Cell CRISPR Screens

High-resolution characterization of gene function using single-cell CRISPR tiling screen

A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells

A high-throughput CRISPR interference screen for dissecting functional regulators of GPCR/cAMP signaling

CRISPRi with barcoded expression reporters dissects regulatory networks in human cells

Multiplexed CRISPR technologies for gene editing and transcriptional regulation

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Multiplexed Gene Engineering Based on Dcas9 and Grna-Trna Array Encoded on Single Transcript.

Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes